A new drug-approval system from Johnson & Johnson will employ an independent panel to review requests from seriously ill people who want to try an unapproved drug without
participating in the actual testing of the drug. A committee of doctors, bioethicists and patient representatives will work under the umbrella of the New York University School of Medicine, and will
field the hundreds of requests J&J receives.
Read the whole story at Consumerist »